Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Six vs Twelve Weeks Antibiotics for Diabetic Foot Osteomyelitis
NCT02123628Phase 4Completed
- Sponsor
- Centre Hospitalier de Tourcoing
- Start
- Jun 2007
- Primary completion
- Jun 2010
- Modality
- Reversible Covalent Inhibitors, Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rifampicin, levofloxacin, doxycycline, trimethoprim + sulfamethoxazole, fusidic acid in diabetic foot osteomyelitis (DFO), sponsored by Centre Hospitalier de Tourcoing. Started Jun 2007; status: completed.
02
Drugs
rifampicinlevofloxacindoxycyclinetrimethoprim + sulfamethoxazolefusidic acid
03
Conditions
diabetic foot osteomyelitis (DFO)
Beyond the preview
Go deeper on NCT02123628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02123628.